Now Enrolling

Reducing Sleep disTurbance in Cancer (REST-C): A study to compare the effectiveness of two different wellness-based mobile apps on blood cancer patient outcomes

Principal Investigators

dr mesa

 

Ruben Mesa MD, FACP, is the vice dean for cancer programs at Wake Forest University School of Medicine and executive director of the Atrium Health Wake Forest Baptist Comprehensive Cancer Center. He is an internationally known expert who has dedicated his career to research and drug development for blood cancers and disorders.

 

dr huberty

 

Jen Huberty, PhD is an accomplished behavior research scientist with over 20 years of experience leading academic and industry-based science using digital approaches to change behavior and improve well-being.

 

Co-Investigators

Supreet Kaur, MD

 

Supreet Kaur, MD is a hematologist oncologist at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center. Her current research interests include clinical biomarkers in cancer and therapeutics. She serves as principal investigator and co-investigator in a number of clinical trials, including SWOG cooperative group studies.

 

About this study

This trial aims to study the effectiveness of two different wellness-based mobile apps on blood cancer patient outcomes, including sleep, fatigue, anxiety, depression, and blood biomarkers of inflammation (TNF-a, IL-6, IL-8, CRP). The findings of this study may help physicians and researchers better understand how mobile wellness mobile apps can help in managing symptom burden and inflammation in blood cancer patients.

Participation eligibility

Participant eligibility includes factors such as age, cancer diagnosis, treatment status, and more. See below for a complete list of all eligibility criteria that is required for participation in this trial.

Inclusion Criteria:

  • Adults (18 years of age or older) diagnosed with a blood cancer and undergoing active treatment
  • Not currently participating in a therapeutic pharmacologic clinical trial
  • Experiencing moderate sleep disturbances or problems with sleep
  • Own a smartphone and willing to download two mobile apps
  • Willing to be randomized
  • Willing to drive to a nearby lab for blood draws 3x during the study over the course of 20 weeks (8-week intervention period followed by 12-week follow-up period)
  • Able to read/understand English

Exclusion Criteria

  • Current meditation practice or meditative movement practice (i.e., yoga, tai chi, qi gong) of 60 min/week in the past 2 months
  • Reside outside of the United States of America
  • Any planned change in pharmacologic therapy (i.e., new drug) or allogenic stem cell transplantation during the study timeframe (i.e., 20 weeks)
  • Current diagnosis of a sleep disorder (except insomnia)
  • Identified as high risk for sleep apnea
  • Currently taking prescribed sleep medications, over-the-counter drugs, and/or supplements more than 3 times per week
  • A diagnosis of certain medical or psychiatric condition
Find out if you are eligible

In order to determine whether you are eligible to participate, we will ask you some brief screening questions. Some of the information collected will include your name, age, contact information, information about your cancer diagnosis and any ongoing treatment, your current mental and physical health, and your sleep habits. This survey should take only 5-10 minutes to complete.

Take the survey